ACE2 and metabolic dysfunction-associated steatohepatitis: Results from a recent (relatively small) cohort study comparing patients with obesity (n = 20) and patients with obesity and NASH (n = 17) demonstrated that ACE2 and TMPRSS2 are upregulated in the liver of patients with NASH,88 making the liver another potential target organ for SARS‐CoV‐2 infection.